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Coronary bifurcation lesions including unprotected distal left main stenosis remains
challenging for percutaneous coronary interventions. This review will summarize the
classification, histopathology and physiology of bifurcation lesions, as well as lessons
learned from bench testing, different stenting strategies and two stent techniques
including dedidated bifurcation devices.
Due to the variety of anatomical configurations the Medina classification of bifurcation
lesions is widely accepted. Lessons from histopathology reveals location of the athero-
sclerotic plaques most frequently in the lateral walls of both main vessel and side branches
in the areas of low shear stress with turbulent flow. The diameter of the mother vessel is
the sum of the daughter vessel diameters (distal main plus side) multiplied by 0.68
(Dm¼0.678 /D1þD2/). In vitro bench testing of bifurcation stenting allows visualization of
stent deformations and lumen reductions after deployment of one or two stents. The role
of final kissing inflation, proximal optimization technique, one or two stent strategy and
different two-stent techniques are addressed (provisional T-stenting, TAP, crush, culotte,
SKS, V-stenting). The role of imaging techniques is emphasized (IVUS, FFR and OCT)
especially for the distal LMCA bifurcation lesions requiring the use of more advanced
devices and specialized techniques as well as adjunctive pharmacologic agents.
Dedicated bifurcation devices and their potential indications are described. Practical tips
and recommendations based on the European Bifurcation Club consensus are presented.
  2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z.o.o.
All rights reserved.
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Percutaneous coronary intervention (PCI) is widely accepted
method of myocardial revascularization, life-saving in acute
myocardial infarction with ST segment elevation (STEMI),
superior to medical treatment in acute coronary syndromes
(ACS) and concurrent to coronary artery bypass graft surgery
(CABG) in many stable patients. With increasing complexity
of coronary artery disease long term results of PCI decline
due to cummulative risk of restenosis, while CABG results are
not affected by lesion complexity itself. Drug eluting stents
led to dramatical decrease in restenosis within first year after
the procedure, but some situations remains challenging for
catheter treatment, namely bifurcation lesions, left main
lesions and chronic total occlusions.2. Definition of bifurcation
Anatomical definition: bifurcation lesion is a lesion occurring
at, or adjacent to, a significant division of a major epicardial
coronary artery. Simple description of bifurcation lesion is
difficult due to the variety of anatomical configurations, sizes
of the main vessel (MV) and side branch/es (SB), stenosis
location and severity, presence of calcifications, angles between
main branch and side branch/es. The main vessel is the largest
and/or the longest vessel. Definition of significant side branch is
related to the volume of vascularized myocardium or vessel
diameter (in most cases 2.25 mm and bigger), while functional
definition is related to the potential consequences of SB occlu-
sion in the global context of a particular patient (symptoms,
viability, collaterals, left ventricular function, etc.). The only
classification which indicates the position of lesions and is easy
to use in everyday life is the Medina classification [1]. It is
comprised of three numbers and two commas. The first
number represents the proximal main vessel segment, the
middle number is the distal main vessel segment and the third
number represents the SB. ‘‘1’’ accounts for the presence and
‘‘0’’ for the absence of 450% stenosis. This classification was
accepted by the general consensus from the second meeting of
the European Bifurcation Club.2.1. Pathology and physiology
Pathologic examination of coronary arteries and intravascular
ultrasound studies reveals that location of the atherosclerotic
plaques most frequently occurs in the lateral walls of bothmain
vessel and side branches, while it is uncommon in the carina
region [2].
Endothelial shear stress (ESS) is the tangential force exerted
on the endothelial surface which results from the friction of the
flowing blood. The pattern of fluid flow depends on the flow
velocity and the presence of irregularities or obstructions. Flow
is either laminar or turbulent. In a straight segment flow is
laminar and undisturbed, and pulsatile ESS is varying between
15 and 70 dyne/cm2 over the cardiac cycle. In irregular regions,
like bifurcations, disturbed laminar flow (with areas of flow
separation and recirculation) generate low and/or oscillatory
ESS (o10–12 dyne/cm2). Low ESS typically occurs at the inner
areas of curvatures and upstream of stenoses. Oscillatory ESS
occurs primarily downstream of stenoses, at the lateral walls of
bifurcations and in the vicinity of branch points. The wide
angulation of the side branch take-off intensifies flow perturba-
tions, increases the spatial ESS variations and low ESS in the
lateral wall, thereby augmenting the atherogenesis. The ESS
variations are augmented by pulsatile flow, which generates an
oscillatory ESS and constitutes a proatherogenic factor. High
heart rate prolongs the exposure of the coronary endothelium
to the impaired systolic flow conditions of low and/or oscilla-
tory ESS [3]. Regions exposed to the non-uniform and low shear
stresses develops early atherosclerotic lesions (areas of mini-
mum shear stress are mainly along the inner side of the curved
coronary arteries) while areas exposed to uniform shear stres-
ses (flow dividers) are usually, but not always, protected.
Atherosclerotic plaque usually develops opposite of the side
branch and the samemechanism stimulate intimal hyperplasia
and in-stent restenosis following stent implantation. Thus, high
restenosis rates are expected with bare metal stents, which
could be offset by drug eluting stent placement.
Although there is a correlation between the stenosis
severity of the side branch (SB) and its physiological signifi-
cance following stent implantation in the main vessel (MV),
Koo has shown that about 70% of ostial SB lesions following
MV stenting are not functionally significant. In this study [4],
no lesion witho75% SB stenosis by QCA had a fractional flow
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 1 7 6 – e 1 8 7e178reserve (FFR)o0.75. Wide variations in FFRs were shown even
in SB lesions with 475% stenosis by QCA suggesting that in
some cases ‘‘significant’’ side branch lesions after main
branch stenting should not be treated. On the opposite side,
in this study, final kissing balloon inflation of functionally
significant SB stenosis (FFRo0.75), was associated with excel-
lent clinical outcome. Therefore, FFR assessment of SB ostial
lesions after MV stenting or the use of a better angiographic
cut-off value may be advocated before stenting of the SB.
2.2. Fluid dynamics
In a conventional scheme of bifurcation the ‘‘main vessel’’
diameter is conserved before and after the origin of ‘‘side
branch’’. The true representation of bifurcation is a mother
vessel dividing into two daughter vessels. Strict relations are
obtained between the flow rates and diameters of the three
vessels. The diameter of the mother vessel is systematically
greater than that of the larger daughter vessel. The sum of flow
rates (Q) in two daughter vessel equals the flow rate in mother
vessel (Qm¼Qd1þQd2). Finet et al.’s adaptation [5] of Murray’s
law [6] calculates that the proximal mother (main) vessel is the
sum of the daughter vessel diameters (distal main plus side)
multiplied by 0.68 (Dm¼0.678 /D1þD2/). This rule should be
kept in mind: the proximal main vessels and distal main vessels
are not the of the same diameter (see the POT technique).
2.3. Bench testing
In vitro bench testing of bifurcation stenting allows visualiza-
tion of stent deformations and lumen reductions after
deployment of one or two stents into a silicone model tubes
(anatomically correct phantoms). Virtual bench testing is a
numerical technique using dedicated software to predict
strut deformations occurring during bifurcation stenting in
idealized or artificial models.1. Stent design: one important factor is the size to which the
stent cells can be expanded by balloon dilatation. Using
stents with large cell sizes reduces the possibility of
compromising SB lumen2. Single main vessel stenting: stenting over SB (without final
kissing dilatation) leaves stent struts across side branch,
which leads to disturbation of laminar flow, low ESS and
recirculation, therefore increasing the risk of stent throm-
bosis and side branch stent restenosis. On the opposite, SB
ostium dilatation produce MV stent distortion and malap-
position opposite to SB [7] and must be corrected by final
high pressure MV dilatation or final kissing inflation (FKI).
For the stent cell design, optimal SB access is only when a
cell is centrally placed with respect to the SB ostium. The
amount of ostial SB scaffolding is affected by the site of
guidewire recrossing and distal cell recrossing is recom-
mended. Before recrossing, underdeployement of the
proximal part of MB stent shoud be corrected by inflating
short and bigger balloon just proximal to the carina with
restoration of the original anatomical configurance (prox-
imal optimization technique—POT)3. T-stenting: the main problem of T stenting is the precise
placement of SB stent. A too distal deployement results inincomplete scaffolding, while too proximal leaves struts in
the MV. Therefore the T-stenting with the small protrusion
technique have been proposed (TAP-stenting). After MV
stenting, the SB stent is positioned with a small protrusion
to the MV with uninflated balloon within the MV before
deploying the SB stent. After FKI a small neo-carina is
present. This technique is usefull in bifurcations with wide
angles (unless single stent strategy is not possible).4. Crush stenting: complex stent deformations are induced by
crush stenting. With the aim of providing complete ostium
scaffolding gaps in strut scaffolding have been observed at
the distal side of SB ostium after postdilatation. Despite
optically good angiographical results, three layers of struts
(and excessive drug release) in MB, difficulties in recross-
ing SB with excessive stent deformations are predictors of
high stent thrombosis rate and restenosis [8].5. Culotte stenting: this technique reguires postdilatation
through both the SB and MV stents to reduse the amount
of ‘‘floating struts’’ with distal recrossing and FKI. There-
fore stents with open cell desing should be selected, this
technique is usefull when dealing with large SB and sharp
division angle [9].6. V-stenting: this technique consist of simultaneous deploye-
ment of two stents from MV into two daughter vessels.
These two stents form relatively long metallic ‘‘neo-car-
ina’’ in the MV. A typical problem is uneven expansion in
the MV segment, especially when using different stent
sizes, and twisting of the stents. Although this technique
is quick and easy, the substatntial metallic carina predis-
pose to MV thrombosis.7. Dedicated stent systems: in vitro testing may help to under-
stand and improve the products in the early phase of their
development.3. IVUS, FFR and OCT in bifurcations
Coronary bifurcation lesion assessment with IVUS before inter-
vention is valuable in angiographically intermediate lesions (to
assess the severity of disease), left main (LMCA) lesions (char-
acterizing distal LMCA lesion significance and morphology to
ensure the lesion requires treatment) and ostial side branch
lesions (to predict carina shift with increased risk of side branch
occlusion). It has been demonstrated that IVUS determined
minimal lumen diameter (MLD) and minimal lumen area (MLA)
cut off values of 2.8 mm and 5.9 mm2, respectively, predict the
physiological significance of a LMCA stenosis (well correlated
with FFR cut-off point 0.75). IVUS guidance of PCI help to select
the appropriate stent size and length, optimally expand the
stent avoiding malapposition and incomplete lesion coverage
after stenting, especially in two stent techniques [10]. Stent
underexpansion, incomplete coverage of the SB ostium and
stent deformations in the MV are predictors of restenosis and
stent thrombosis. Routine use of IVUS in the unprotected LMCA
interventions in the large MAIN-COMPARE multicentre registry
showed a strong trend towards a lower mortality with IVUS
guidance [11]. IVUS taught us about different stenting techni-
ques and is used in a novel dedicated bifurcation stents (very
low neointimal hyperplasia in the MV DES and dedicated Tryton
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diffusion of the antiproliferative drug).
Fractional flow reserve (FFR) represents the fraction of
maximal myocardial flow that can be maintained in the
presence of epicardial stenosis and is obtained by the ratio
of distal coronary pressure and proximal coronary pressure.
FFR can be used for the evaluation of the functional signifi-
cance or the necessity of revascularization [12]. As the
bifurcation lesion is basically the combination of three
lesions, FFR overestimates the severity of SB lesion if there
is a significant proximal stenosis. In contrast FFR under-
estimate the lesion severity when there is a significant distal
lesion. It has been shown that geometric changes after MV
stent implantation, carina shift and plaque shift are asso-
ciated with SB jailing, but this is difficult to predict. Results
from the Nordic Baltic Bifurcation III trial suggest that the
angiographic evaluation overestimates the severity of jailed
SB lesions and that functional status of jailed SB lesions after
DES implantation does not change during follow up [13].
Therefore only significant SB lesions (DS475% or FFRo0.75)
should be stented, this further emphasize the role of simple
stenting techniques. FFR for complex stenting strategies is
not generally applicable for the complexity of procedure and
difficulties of re-crossing with FFR guidewire.
The optical coherence tomography (OCT) allows for assess-
ment not just strut apposition (proximal MV, ostium of the
SB, stent overlap), but also endothelisation at follow up. It has
been shown that paclitaxel eluting stents have the highest
proportion of uncovered struts in the SB ostium, while
sirolimus eluting stents in the main vessel opposite the
ostium. This demonstrate some of the inadequacies of our
existing stent technologies and the need of new bifurcation
stenting technologies (dedicated DES). Routine clinical appli-
cation of OCT is still limited [14].4. Techniques description
4.1. Stenting main vessel only
This is easy technique with single wire and MV stent across
side branch, usefull in all 1,1,0, 0,1,0 or 1,0,0 lesionsFig. 1 – (a–c) Single stent technique. Ostial LAD critical lesion, NS
with an anchoring wire in the intermediate branch. The ancho
(after partial stent inflation and subsequent manual crimping—(Figs. 1a–c). Stent size is respecting the distal MV diameter.
To solve the problem of underdeployment of the proximal
part of the MV stent inflation with a short and bigger balloon
(0.5 mm bigger noncompliant balloon) just proximal to the
carina is performed—so called proximal optimization tech-
nique (POT) to respect Murray’s law (this also facilitate the
insertion of the guidewire, balloon or stent into the SB). Final
kissing is not mandatory, unless side branch is not large and
significant—the role of FKI is to oppose struts over SB to
vessel wall.
4.2. Final kissing inflation (FKI)
The final kissing inflation (FKI) is important to correct stent
distortion and expansion, fully expanding the stent in the
proximal MV where the diameter is much larger, providing
better scaffolding of the SB ostium. The Nordic-Baltic Bifur-
cation study III look at the role of FKI after MV stenting. The
6-month major adverse cardiac event rates were 2.1% and
2.5% (P¼1.00) in the FKI and no-FKI groups, respectively. At 8
months, the rate of binary (re)stenosis in the entire bifurca-
tion lesion (MV and side branch) was 11.0% versus 17.3%
(P¼0.11), in the MV was 3.1% versus 2.5% (P¼0.68), and in the
side branch was 7.9% versus 15.4% (P¼0.039) in the FKI versus
no-FKI groups, respectively. In patients with true bifurcation
lesions, the side branch restenosis rate was 7.6% versus 20.0%
(P¼0.024) in the FKBD and no-FKBD groups, respectively [15].
4.3. T-technique
This is the most frequently used technique with several
modification from provisional stenting to stenting the SB
and is most suited for bifurcations where the angle between
the branches is close to 901.TEM
r w
b).Provisional T technique: place wire in the SB, second wire in
the MV and stent the MV. If the SB result is unsatisfactory,
use POT technique, rewire the SB through distal strut and
after balloon dilatation implant second stent to the SB and
perform FKI with high pressure noncompliant balloons
(Figs. 2a-e). Ideal technique to avoid the second stent, if
the SB lesion is short (o3 mm).I, Medina type 0,1,0 (a) Stent (DES 4.0/8 mm) positioned
ire is advanced through last proximal strut of the stent
Final result after implantation (c).
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Ste
se
FKClassical T-technique: position a stent at the ostium of the
SB, avoid protusion into the MV, deploy the stent and
remove balloon. Advance and deploy the MV stent, re-wire
the SB, remove jailed wire, perform SB dilatation and FKI. Modified T-technique: is a variation performed by simulta-
neously positioning stents in the SB and MV. The SB stent
is deployed first, after balloon removal from the SB, the
MV stent is deployed, followed by FKI. Ideal technique
when the angle between the braches is close to 901, larger
guiding is required (7F). In lesions 0,0,1 useful technique,
sometiomes avoiding the MV stenting.
4.4. T and protrusion (TAP)
This is a modification of provisional T, compatible with 6 Fr
guiding catheters. After the MV stenting the SB is wired
(jailed wire removed), after balloon dilatation the SB stent is
positioned with a small protrusion to the MV with uninflated
balloon within the MV before deploying the SB stent. After
FKI a small neo-carina is present (Figs. 3a–c).
4.5. The culotte technique
The culotte technique provides near perfect coverage of the
carina and SB ostium with the best immediate angiographic. 2 – (a–e) Provisional T technique. Distal LMCA calcified bifurca
nt (DES 3.5/24) deployed from ostium of LMCA into RCX (b),
cond stent (DES 3.5/13 mm) positioned at the ostium of LAD an
I with noncompliant balloons (e).results. Both branches are wired and pre-dilated. A first stent
is deployed to the SB (most angulated branch), the MV is
rewired ad dilated. A second is deployed into the MV, the SB is
rewired and FKI with noncompliant balloons at high pressure
(416 atm) individually before last simultaneous inflation at
10 atm. Stenting the branch with the sharpest angle is
recommended first, however in case of large dissection after
predilatation there is a risk of closure of the secondly stented
vessel and main vessel should be stented first (Figs. 4a–e).
The culotte technique is compatible with a 6 Fr guiding
catheters.
4.6. The crush technique
Assures immediate patency of both branches – important when
the SB is functionally relevant and difficult to wire. The classical
crush technique has evolved and is performed with less SB stent
protrusion into the MV – the ‘‘mini-crush’’. Both branches are
wired and fully dilated, the SB stent is positioned and the MV
stent is advanced. The SB stent is pulled back to the MV about
1–2mm (verified in 2 projections), deployed at least at 12 atm,
balloon deflated and removed. Then the stent in the MV is
deployed at high pressure. The SB stent is re-wired and two step
FKI performed—first step is dilatation of the stent towards the SB
at 16 atm, then FKI with an inflation pressure 10–14 atm in both
balloons. This technique can be used in almost all truetion lesion, stable angina, post CABG, Medina type 1,1,1 (a).
proximal optimization with 4.5/8 mm (c), rewiring LAD and
d deployed with balloon in LCX inflated (d), final result after
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 1 7 6 – e 1 8 7 e181bifurcation lesions but should be avoided in wide angle bifurca-
tions. The main limitation is the need to re-cross multiple struts
with wire and balloon to perform FKI. This technique, due to
simultaneous advancement of two stents, requires a 7 Fr guiding
catheters. The ‘‘step-crush’’ is themodified balloon crush adapting
this technique to a 6 Fr guiding catheters. This modification use
balloon instead of stent in the MV for crushing the protrusion of
SB stent followed by positioning and deployment of the MV stent
with FKI (Figs. 5a–e). Another modification is the double kissing
crush (DKI) as a modification of the step crush where kissing
inflation is performed twice: firstly after the SB is crushed by the
MV balloon and secondly the routine FKI at the end of procedure.
4.7. Simultaneous kissing stents (SKS) and V-technique
These techniques are performed by delivering and implant-
ing two stents together. One stent is placed into the SB and
the opther into the MV. Both stents are pulled back to create a
new carina (very short in V-technique and longer, double
barrel in SKS technique), each stent is deployed individually
at high pressure with medium pressure FKI. The V stenting isFig. 3 – (a–d) T and protrusion technique. Distal LMCA trifurcation
branch (considered as MV—a). After stenting the intermediate b
and sequentially stented (DES 2.5/8 mm in both branches) with a
kissing inflation small neo-carina is present (c, d).relatively easy (usefull in emergencies) and ideal in Medina
0,1,1 lesions with large proximal MV free of disease (ostial
LAD and LCX disease with short and large left main free of
disease). The long term risk of stent thrombosis is expected
to be higher related to the unapposed and uncovered struts in
the metallic neo-carina, in case of restenosis difficulties with
re-crossing and frequent stent deformations requires con-
verting to the crush technique.5. One or two drug eluting stents
Drug eluting stents have been shown to minimize the
angiographical and clinical restenosis by more than 80%
and 50% respectively. With these stents several randomized
studies in bifurcation lesions were published.1., N
ran
smThe NORDIC Study used sirolimus eluting stents in a
randomised comparison of main vessel stenting versus
stenting of both MV and SB using several different tech-
niques. Only 2.7% of patients randomized to MV stentingSTEMI, Medina type 1,1,1,1, the biggest is intermediate
ch (DES 3.5/20 mm across LAD and LCX), both SB rewired
all protrusion into the main vessel (b). After double final
Fig. 4 – (a–e) The culotte technique. Distal LMCA bifurcation lesion, Medina 1,1,1, diffuse mid LAD 70% stenosis, severe LCX/OM
bifurcation lesion (Medina 1,1,0), diffusely diseased RCA, NSTEMI, SYNTAX Score 32, EuroScore 10.8% (a). After stenting LCX
(DES 3.5/30 mm) with FKI, second stent (DES 3.5/24 mm) is positioned from ostium of LMCA into LAD and deployed (b). LCX is
rewired and third stent (DES 4.3/24 mm) is positioned from the ostium of LMCA into the LCX (c) and deployed. Final result
after FKI with high pressure balloons (d, e).
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 1 7 6 – e 1 8 7e182only received second stent in the SB, MACE rate at 6
months was very low in both gloups (2.9% versus 3.4%
respectively). After 14 months the rates of MACE were
9.5% in the MV group and 8.2% in the MVþSB group (ns),
no difference was found in stent thrombosis [16].2. The BBC ONE study randomised patients with bifurcation
lesions (82% true bifurcations 1,1,1–1,0,1 or 0,1,1) to a
provisional T strategy versus complex culotte or crush 2
stents. The MACE rate was 8% for simple versus 15% for
comples treatment, largely driven by a higher incidence of
periprocedural myocardial infarction [18].3. The CACTUS study compared crush stenting with provi-
sional T strategy (FKI mandatory in both groups). The
primary endpoint (6-mionth MACE) was not different (15%
versus 16%) and there was no differnce in the rate of
restenosis [19].4. The NORDIC stent technique study [17]: patients with a
bifurcation lesions were randomized to crush and culotte
stenting. At 6 months there were no significant differ-
ences in MACE rates between the groups; crush 4.3%,
culotte 3.7% (P¼0.87). The rates of procedure-related
increase in biomarkers of myocardial injury were 15.5%
in crush versus 8.8% in culotte group (P¼0.08). Angio-
graphically, in-stent restenosis was significantly reducedfollowing culotte versus crush stenting (4.5% versus
10.5%, P¼0.046).Metaanalysis of simple versus complex stenting strategy for
DES treatment of coronary bifurcation lesions [20,21] revealed nosignificant differences with respect to the rates of cardiac death,
target lesion revascularisation or definite stent thrombosis (ST).
The restenosis risk of MV and SB did not differ between the
simple strategy group and the complex strategy group. The risks
of in-hospital or 30-day and follow-up myocardial infarction (MI)
were markedly lower in patients treated with the simple strategy
compared to the complex strategy. The simple strategy can be
recommended as a preferred bifurcation stenting technique in
the DES era and FKI is recommended to decrease side branch
restenosis. Complex two-stent strategy is recommended if a SB
stenosis exceeds 70% in diameter for more than 5mm in length,
supplying clinically significant territory of viable myocardium
(42.5 mm in diameter). The ongoing BBC TWO and NORDIC IV
are probably to be the last randomizing (non left main) bifurca-
tions into one versus two stent strategy. Experienced operators
use both of these techniques respecting more anatomy and
physiology rather than selecting ‘‘simple’’ cases to avoid complex
strategy. Dedicated bifurcation stents are expected to play a role,
particularly for left main stem.
Fig. 5 – (a–e) The ‘‘step-crush’’ technique. LAD/D1 bifurcation lesion, NSTEMI with D1 as a culprit vessel, Medina 1,1,1 (a). Both
branches are wired and predilatated. The SB stent (DES 2.5/15 mm) is advanced and positioned with a small 1–2 mm
protrusion into the LAD, while maintaining balloon in LAD (2b). After SB stenting and SB balloon removal, LAD balloon
crushes the protrusion of stent, LAD stent (DES 3.5/24 mm) is positioned and deployed (c), the side branch is rewired. Final
result after FKI (d,e).
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Marked technical advances in PCI, stent technology and
availability of DES has led to re-evaluation of the role of PCI
as a viable alternative treatment for unprotected LMCA
disease. The choice of PCI or CABG depends on several
clinical and anatomic features. PCI of unprotected LMCA
disease has comparable safety and efficacy outcomes to
CABG in following left main patient subsets: ostial and/or
shaft left main disease, isolated left main disease, left main
disease plus single vessel disease, distal bifurcation left main
disease treatable by single stent (cross-over approach) and
left main with low concomitant disease severity (Syntax
scoreo23). However, true distal LMCA bifurcation lesions
require unique and more integrated approach that combines
more advanced devices with specialized techniques, adjunc-
tive imaging support as well as adjunctive pharmacologic
agents. Respecting the geometry and stent design, the T-
stenting and culotte stenting IVUS assisted techniques are
recommended on the basis of vessel size, bifurcation angula-
tion and degree of obstruction of the SB. In a recent metaa-
nalysis of four randomized trials at 12-month follow-up PCI,
as compared to CABG, was associated with a significant risk
reduction of stroke (0.12% versus 1.90%, P¼0.004), with anincreased risk of repeat revascularization (11.03% versus
5.54%, Po0.001) and similar risk of mortality and myocardial
infarction [22–25]. Large randomized trial is ongoing (EXCEL)
and dedicated LMCA bifurcation stents are currently being
explored (Axxess stent, Tryton stent).7. Dedicated bifurcation devices
Many devices are already under clinical investigation [26].
They may be devided into 4 groups: 1. devices treating the MV
with some degree of SB scaffolding (Xience SBA, Stentys,
Petal, Twin-Rail, Nile), 2. side branch stents (Sideguard,
Tryton), 3. proximal bifurcation stents (Axxess), 4. bifurcated
stents (Medtronic).
The XIENCE SBA (side branch access) is a modified Xience V
stent designed with an open portal for side branch access
(Fig. 6). It is a double balloon, single shaft delivery system
(similar to the FRONTIER stent). The stent is a cobalt–
chromium DES (everolimus, permanent polymer) 18 mm in
length and 2.5 and 3.0 mm in the MV diameter. After
predilatation of the MV and the SB, the stent is delivered
over a rapid exchange single extra support wire into the MV
beyond the SB, then the joining mandrel is removed to
separate the tip of the SB balloon, stent is pulled back and
Fig. 7 – STENTYS Self-Apposing stent.
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careful rotation to prevent wire twisting). Then the device is
advanced into the bifurcation, forward tension is held to
maintain the position and stent is deployed by inflation
through a single inflation lumen. Compatible with 6 Fr
guiding catheters.
The STENTYS Self-Apposing Stent is a self-expandable national
closed cell design stent intended for side branch angulation
between 301 and 701. The stent conforms to the shape of
the artery and is available in three diameters (2.5–3.0 mm,
3.0–3.5 mm and 3.5–4.5 mm), two lengths (22 mm and 27mm)
and BMS or DES (paclitaxel 0.8 mg/mm2) versions. At the
carina, after disconnection, the stent expands to a maximum
of 6.6 mm. The rapid-exchange delivery system allows the
stent to be positioned and delivered in the MV by withdrawing
a retractable sheath, disconnection at the SB is done by wire
crossing at the carina level and balloon dilatation. If needed,
any stent can be deployed into the SB (Fig. 7). In an APPOSI-
TION II randomized trial the stent showed a 10-fold reduction
in stent strut malapposition compared to balloon expandable
stents. Compatible with 6 Fr guiding catheters.
The Sideguard Stent is a bare 8 or 14 mm long self-expanding
nitinol stent indicated for bifurcation angles from 451 to 1351.
It flares proximally at the ostium of the SB into a trumpet
shape to achieve full ostial coverage (Fig. 8). After predilata-
tion of the SB the Sideguard stent is advanced while
three proximal and two distal radiopague markers aid posi-
tioning of the stent and allow angiographic visibility post
implantation. Inflation of the balloon tears the protective
sheath that enables self-expansion of the Sideguard stent.
The delivery system and the guidewire is removed from the
SB and main vessel is stented. Available in three sizes
2.5 mm, 2.75 mm and 3.25 mm, compatible with 6 Fr guiding
catheters.
The Tryton Stent is a balloon expandable cobalt chromium
side branch stent with free distinct zones: a distal SB zone
(slotted tube design), a central transition zone(three panels)
and proximal MV zone (free undulating fronds that terminate
proximally in two wedding bands). The stent is available in
one length of 19 mm (the SB zone is 8 mm long) premounted
on a stepped balloon with the SB diameters of 2.5 mm,
3.0 mm and the proximal diameter of 3.0 mm and 3.5 mm.
After wiring of both the MV and SB and predilatation, the
Tryton stent is advanced into the SB and positioned till twoFig. 6 – Xience SBA stent.middle markers straddle the SB origin. After deployment the
SB wire is retracted and repositioned through the fronds into
distal MV, main vessel DES is advanced and deployed with
recrossing the SB and FKI (Fig. 9). This stent can be used in a
wide range of bifurcation angles, locations as well as for left
main stenting (3.5–4.0 mm version). Compatible with 6 Fr
guiding catheters.
The AXXESS Biolimus A9 Eluting Coronary Bifurcation Stent
System is a self-expanding conically shaped laser-cut nitinol
drug eluting stent with 150 mm strut thickness on a rapid
exchange delivery system upon withdrawal of a cover sheath.
Optimal deployment is guided by progressive flaring of three
gold markers to effectively cover the proximal part of the MV
and protrude over carina level (Fig. 10). The current version
can accomodate vessels from 2.75 mm to 4.25 mm in two
lengths (10 and 14 mm), special version is available for left
main bifurcation lesions (up to 4.75 mm). Delivery is through
a 7 Fr approach, after the proximal MV stenting one or two
conventional DES is deployed into the distal MV and the SB
respectively.
The Medtronic Bifurcation Stent System is a bare metal (cobalt
based alloy) Y-shaped stent that consist of a 12-crown 7 mm
proximal main vessel section, an 8-crown 4 mm side branch
section and 8 mm distal main vessel section available in two
versions, one with a proximal MV diameter of 3.8 mm, distalFig. 8 – Sideguard stent.
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MV diameter of 4.3 mm, distal MV 3.5 mm and SB
2.5 mm. The stent is pre-mounted on a dual rapid exchange
delivery system, uses two balloons (the SB balloon uses a
stepped design to match the anatomy) compatible with 8Fr
guide catheters (Fig. 11). This device is intended for bifurca-
tion angles less than 90 degrees. Like other self-alignment
devices (Taxus Petal, Nile-PAX, Twin-Rail, Trireme, SideKick)
guidewire twisting may limit proper stent positioning with
the risk of miss alignment, especially when the vessel is
calcified or tortuous, with a disappointing rate of device
success.8. Practical tips
When planning an interventional strategy for bifurcation
lesion PCI several practical tips are recommended by the
consensus from the 2nd and the 5th European Bifurcation
Club meetings [27,28].Fig. 10 – AXXESS stent.
Fig. 11 – Medtronic Bifurcation Stent System.
Fig. 9 – TRYTON stent.1. The proximal MV diameter is larger compared to distal
MV diameter (by Murray’s law), the primary stent should
be sized according to the distal MV diameter and prox-
imal MV segment should be postdilated with larger (or
kissing) balloon inflations to optimize the proximal stent
diameter (the POT technique).2. Side branch diameter and area of muscle mass are
responsible for functional significance of the SB.3. Side branch lesion severity, length and the angle of
bifurcation are responsible for selection between one or
two stent strategy.4. Jailed wire technique should be routinely used in func-
tionally significant SB and in SB lesions whose access is
particularly challenging.5. The POT technique should be used prior to wire recross-
ing into a SB, efforts should be made to cross the main
vessel stent distally, thereby ensuring stent coverage of
the ostium of the SB (last strut technique).6. The T techniques remains the gold standard for most
bifurcations with a single stent implantation.7. FKI should be used when an angiographically signi-
ficant (475%) SB lesion remains after main vessel stent-
ing and is mandatory in all unprotected LMCA
bifurcations.8. Large side branches with ostial disease extending45 mm
from the carina are likely to require a two stent strategy.
When two stents are required, the culotte technique
offers advantages over crush stenting.9. FKI is mandatory in any two stent techniques with
individual non-compliant high pressure ostial post-infla-
tions and final high pressure proximal MV stent inflation
to correct possible MV stent distortion.10. Dedicated bifurcation stent systems remain limited but
are likely ultimately to prevail.
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 1 7 6 – e 1 8 7e1869. ConclusionsThe strategy of provisional SB stenting is widely accepted in
suitable bifurcation lesions and is accompanied by low rates
of stent thrombosis. However it is not applicable to all lesions
and clinical situations and 10% or more require two stents. To
avoid excessive metal scaffolding the classical crush techni-
que should be avoided, replaced by culotte, T and protrusion
or mini-crush techniques. Dedicated bifurcation devices
must improve procedural outcome by simplifying the inter-
vention and enhancing its safety to gain wider acceptance.
Distal LMCA bifurcation lesions require unique approaches,
more advanced devices and adjunctive imaging for optimal
result. In the meantime maintenance of dual antiplatelet
therapy without interruption with optimal duration at least
12 months is mandatory.
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